OLIVE ECKSTEIN to Antibodies, Monoclonal
This is a "connection" page, showing publications OLIVE ECKSTEIN has written about Antibodies, Monoclonal.
Connection Strength
0.193
-
Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study. Arthritis Rheumatol. 2025 Feb; 77(2):226-238.
Score: 0.155
-
Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab. Blood Adv. 2024 05 14; 8(9):2248-2258.
Score: 0.038